Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

RNAseq of C. elegans cultured on metformin sensitive and resistant E. coli strains with and without 50mM metformin treatment.


ABSTRACT: Metformin is the therapy of choice for treating type 2 diabetes and is currently repurposed for a wide range of diseases including aging. Recent evidence implicates the gut microbiota as a site of metformin action. Combining two tractable genetic models, the bacterium E. coli and the nematode C. elegans, we performed C. elegans RNAseq to investigate the role of the metformin sensitive OP50 and metformin resistant OP50-MR E. coli microbiota in the drug effects on the host. Our data suggest an evolutionarily conserved bacterial mediation of metformin effects on host lipid metabolism and lifespan.

INSTRUMENT(S): Illumina HiSeq 2500

ORGANISM(S): Caenorhabditis elegans

SUBMITTER: Rosina Pryor 

PROVIDER: E-MTAB-7272 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2015-02-27 | E-GEOD-58931 | biostudies-arrayexpress
2023-03-11 | PXD036621 | Pride
2020-09-21 | PXD011579 | Pride
2018-03-13 | PXD008105 | Pride
2023-06-01 | E-MTAB-12289 | biostudies-arrayexpress
2019-01-31 | E-MTAB-6418 | biostudies-arrayexpress
2018-11-01 | E-MTAB-6421 | biostudies-arrayexpress
2020-06-27 | GSE153318 | GEO
| PRJNA1115982 | ENA
2023-02-18 | PXD036826 | Pride